| Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau CA Lasagna-Reeves, DL Castillo-Carranza, U Sengupta, ... Scientific reports 2 (1), 700, 2012 | 536 | 2012 |
| Preparation and characterization of neurotoxic tau oligomers CA Lasagna-Reeves, DL Castillo-Carranza, MJ Guerrero-Muñoz, ... Biochemistry 49 (47), 10039-10041, 2010 | 367 | 2010 |
| Passive immunization with Tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary tangles DL Castillo-Carranza, U Sengupta, MJ Guerrero-Muñoz, ... Journal of Neuroscience 34 (12), 4260-4272, 2014 | 299 | 2014 |
| Tau oligomers: cytotoxicity, propagation, and mitochondrial damage SS Shafiei, MJ Guerrero-Muñoz, DL Castillo-Carranza Frontiers in aging neuroscience 9, 83, 2017 | 262 | 2017 |
| Specific targeting of tau oligomers in htau mice prevents cognitive impairment and tau toxicity following injection with brain-derived tau oligomeric seeds DL Castillo-Carranza, JE Gerson, U Sengupta, MJ Guerrero-Muñoz, ... Journal of Alzheimer's Disease 40 (s1), S97-S111, 2014 | 185 | 2014 |
| Pathological interface between oligomeric alpha-synuclein and tau in synucleinopathies U Sengupta, MJ Guerrero-Muñoz, DL Castillo-Carranza, ... Biological psychiatry 78 (10), 672-683, 2015 | 177 | 2015 |
| Tau oligomers: the toxic player at synapses in Alzheimer’s disease MJ Guerrero-Muñoz, J Gerson, DL Castillo-Carranza Frontiers in cellular neuroscience 9, 464, 2015 | 174 | 2015 |
| Tau immunotherapy modulates both pathological tau and upstream amyloid pathology in an Alzheimer's disease mouse model DL Castillo-Carranza, MJ Guerrero-Muñoz, U Sengupta, C Hernandez, ... Journal of Neuroscience 35 (12), 4857-4868, 2015 | 153 | 2015 |
| Therapeutic approaches against common structural features of toxic oligomers shared by multiple amyloidogenic proteins MJ Guerrero-Muñoz, DL Castillo-Carranza, R Kayed Biochemical pharmacology 88 (4), 468-478, 2014 | 116 | 2014 |
| Soluble tau aggregates, not large fibrils, are the toxic species that display seeding and cross‐seeding behavior G Ghag, N Bhatt, DV Cantu, MJ Guerrero‐Munoz, A Ellsworth, ... Protein Science 27 (11), 1901-1909, 2018 | 107 | 2018 |
| Characterization of tau oligomeric seeds in progressive supranuclear palsy JE Gerson, U Sengupta, CA Lasagna-Reeves, MJ Guerrero-Muñoz, ... Acta neuropathologica communications 2, 1-9, 2014 | 100 | 2014 |
| Dual role of p53 amyloid formation in cancer; loss of function and gain of toxicity CA Lasagna-Reeves, AL Clos, D Castillo-Carranza, U Sengupta, ... Biochemical and biophysical research communications 430 (3), 963-968, 2013 | 98 | 2013 |
| α-Synuclein oligomers induce a unique toxic tau strain DL Castillo-Carranza, MJ Guerrero-Muñoz, U Sengupta, JE Gerson, ... Biological psychiatry 84 (7), 499-508, 2018 | 83 | 2018 |
| The formation of tau pore-like structures is prevalent and cell specific: possible implications for the disease phenotypes CA Lasagna-Reeves, U Sengupta, D Castillo-Carranza, JE Gerson, ... Acta neuropathologica communications 2, 1-13, 2014 | 79 | 2014 |
| Amyloid-β oligomers as a template for secondary amyloidosis in Alzheimer's disease MJ Guerrero-Muñoz, DL Castillo-Carranza, S Krishnamurthy, ... Neurobiology of disease 71, 14-23, 2014 | 67 | 2014 |
| Differential activation of the ER stress factor XBP1 by oligomeric assemblies DL Castillo-Carranza, Y Zhang, MJ Guerrero-Munoz, R Kayed, ... Neurochemical research 37, 1707-1717, 2012 | 57 | 2012 |
| A native interactor scaffolds and stabilizes toxic ATAXIN-1 oligomers in SCA1 CA Lasagna-Reeves, MWC Rousseaux, MJ Guerrero-Muñoz, J Park, ... Elife 4, e07558, 2015 | 35 | 2015 |
| Alzheimer’s disease imaging with a novel Tau targeted near infrared ratiometric probe HY Kim, U Sengupta, P Shao, MJ Guerrero-Muñoz, R Kayed, M Bai American journal of nuclear medicine and molecular imaging 3 (2), 102, 2013 | 25 | 2013 |
| Antibody against small aggregated peptide specifically recognizes toxic Aβ-42 oligomers in Alzheimer’s disease RU Bodani, U Sengupta, DL Castillo-Carranza, MJ Guerrero-Muñoz, ... ACS chemical neuroscience 6 (12), 1981-1989, 2015 | 22 | 2015 |
| Immunotherapy for the treatment of Alzheimer’s disease: amyloid-β or tau, which is the right target? DL Castillo-Carranza, MJ Guerrero-Muñoz, R Kayed ImmunoTargets and Therapy, 19-28, 2013 | 18 | 2013 |
